Zoetis Inc (ZTS) reported quarterly earnings results on Wednesday, May-4-2016. The company said it had a profit of $0.48 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.07. Analysts had a consensus of $0.41. The company posted revenue of $1162.00 million in the period, compared to analysts expectations of $1103.71 million. The company’s revenue was up 5.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.41 EPS.
Zoetis Inc opened for trading at $47.2 and hit $48.1 on the upside on Monday, eventually ending the session at $48.03, with a gain of 2.13% or 1 points. The heightened volatility saw the trading volume jump to 37,05,382 shares. Company has a market cap of $23,878 M.
Zoetis Inc. is engaged in the discovery development manufacture and commercialization of animal health medicines and vaccines with a focus on both livestock and companion animals. The Company markets products across four regions: the United States Europe/Africa/Middle East Canada/Latin America and Asia/Pacific; eight species: the livestock species of cattle swine poultry sheep and fish and the companion animal species of dogs cats and horses and five product categories: anti-infectives vaccines parasiticides medicated feed additives and other pharmaceutical products. In addition its Client Supply Services (CSS) organization provides contract manufacturing services to third parties.